Trial Profile

Randomised trial to compare the clinical value of cyclosporin C12 and C2 monitoring after lung transplantation.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 06 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ciclosporin (Primary)
Indications Lung transplant rejection
Focus Pharmacokinetics

Most Recent Events

16 Sep 2009 Additional lead trial centres and investigator identified as reported by ISRCTN: Current Controlled Trials.
16 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
16 Sep 2009 New source identified and integrated (ISRCTN: Current Controlled Trials record no. ISRCTN17970029).

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com